Only a minority of suspicious mammograms actually leads to a cancer diagnosis, which results in lots of needless worry and spent time for women and their families. Ultrasound elastography could be an excellent screening tool but it requires a lot of skill and interpretation. In an effort to improve results, researchers in Michigan have developed a virtual “breast”, allowing medical professionals to practice in the laboratory.
How the brain ages is still largely an open question because this organ is mostly insulated from direct contact with other systems in the body. In recent research, scientists in Israel found evidence of a unique “signature” that may be the “missing link” between cognitive decline and aging. The scientists believe that this discovery may lead, in the future, to treatments that can slow or reverse cognitive decline in older people.
Chemists in the U.K. have gained fresh insights into how a disease-causing enzyme makes changes to proteins and how it can be stopped. The scientists hope their findings will help them to design drugs that could target the enzyme, known as N-myristoyltransferase (NMT), and potentially lead to new treatments for cancer and inflammatory conditions.
One of the big frustrations of surgery is that little indicates whether the patient is a fast or slow healer, someone who feels normal in a week or is out of work for a month with lingering pain and fatigue. Now Stanford Univ. researchers have discovered that right after surgery, patients' blood harbors clues about how fast they'll bounce back. And it has to do with the activity of certain immune cells that play a key role in healing.
A new wearable medical device can quickly alert a person if they are having cardiovascular trouble or if it’s simply time to put on some skin moisturizer, reports a Northwestern Univ. and Univ. of Illinois at Urbana-Champaign study. The small device, approximately five centimeters square, can be placed directly on the skin and worn 24/7 for around-the-clock health monitoring.
The liver provides critical functions, such as ridding the body of toxins, but its failure can be deadly, and there are few options for fixing it. A promising alternative in development is transplanting liver cells made using adult stem cells, but the only source identified until now has been bone marrow. Recently, scientists identified another, more convenient, source of adult stem cells that could be used for this purpose:tonsils.
Researchers in the Netherlands have managed to open nanovesicles in a reversible process and close them using a magnet. Previously, these vesicles had been “loaded” with a drug and opened elsewhere using a chemical process, such as osmosis. The magnetic method, which is repeatable, is the first to demonstrate the viability of another method.
A Rice Univ. team led by bioengineer Jeffrey Jacot and chemical engineer and chemist Matteo Pasquali have created new pediatric heart-defect patches infused with conductive single-walled carbon nanotubes that allow electrical signals to pass unhindered. The nanotubes overcome a limitation of current patches in which pore walls hinder the transfer of electrical signals between cardiomyocytes, the heart muscle’s beating cells.
A new, ultrasensitive biosensor made from graphene has been used to detect molecules that indicate an increased risk of developing cancer. The biosensor has been shown to be more than five times more sensitive than bioassay tests currently in use, and was able to provide results in a matter of minutes, opening up the possibility of a rapid, point-of-care diagnostic tool for patients.
There's some truth to the effectiveness of folk remedies, according to findings by a team from Detroit Medical Center. Dr. Sonal Saraiya and her colleagues in Michigan found that packing strips of cured pork in the nose of a child who suffers from uncontrollable, life-threatening nosebleeds can stop the hemorrhaging. The discovery won a 2014 Ig Nobel prize, the annual award for sometimes inane, but often practical, scientific discoveries.
Mathematics might be able to reduce the need for invasive biopsies in patients suffering kidney damage related to the autoimmune disease lupus. In a new study, researchers developed a math model that can predict the progression from nephritis, or kidney inflammation, to interstitial fibrosis, scarring in the kidney that current treatments cannot reverse. A kidney biopsy is the only existing way to reach a definitive diagnosis.
For years, neuroscientists have been trying to develop tools that would allow them to clearly view the brain's circuitry in action. To get this complete picture, neuroscientists are working to develop a range of new tools to study the brain. Researchers at Caltech have developed one such tool that provides a new way of mapping neural networks in a living organism.
Fewer than half of all patients who are suspected of having a genetic disease actually receive a satisfactory diagnosis. To solve this problem, scientists have developed an innovative diagnostic procedure, called PhenIX, that combines the analysis of genetic irregularities with the patient's clinical presentation. The method involves a search for genes that cause disease and its related phenotypes to produce a short, testable list.
Building on previous animal and human research, a new study has identified an electrophysiological marker for threat in the brain. The findings illustrate how fear arises in the brain when individuals are exposed to threatening images, and the study is the first to separate emotion from threat by controlling for the dimension of arousal, the emotional reaction provoked, whether positive or negative, in response to stimuli.
Self-injury is one of the most difficult behaviors associated with autism and other developmental or intellectual disabilities, and a private facility outside Boston that takes on some of the hardest-to-treat cases is embroiled in a major debate: Should it use electrical skin shocks to try to keep patients from harming themselves or others?
Things can go downhill fast when a patient has sepsis, a life-threatening condition in which bacteria or fungi multiply in a patient's blood—often too fast for antibiotics to help. A new device inspired by the human spleen and developed by a team at Harvard's Wyss Institute for Biologically Inspired Engineering may radically transform the way doctors treat sepsis.
A simple point-of-care testing device for anemia could provide more rapid diagnosis of the common blood disorder and allow inexpensive at-home self-monitoring of persons with chronic forms of the disease. The disposable self-testing device analyzes a single droplet of blood using a chemical reagent that produces visible color changes corresponding to different levels of anemia.
For detecting cancer, manual breast exams seem low-tech compared to other methods such as MRI. But scientists are now developing an “electronic skin” that “feels” and images small lumps that fingers can miss. Knowing the size and shape of a lump could allow for earlier identification of breast cancer, which could save lives.
New research in Europe suggests that testing the temperature of breath could be a simple and noninvasive method to either confirm or reject the presence of lung cancer. Many research teams have been looking at the possibility of using breath tests for a number of cancers but this is the first study looking at breath temperature as a marker in lung cancer.
A new class of synthetic platelet-like particles could augment natural blood clotting for the emergency treatment of traumatic injuries. The clotting particles, which are based on soft and deformable hydrogel materials, are triggered by the same factor that initiates the body’s own clotting processes.
Up to 30% of people with the most common form of hemophilia develop antibodies that attack lifesaving protein injections, making it difficult to prevent or treat excessive bleeding. Now researchers have developed a way to thwart production of these antibodies by using plant cells to teach the immune system to tolerate rather than attack the clotting factors.
Eli Lilly and Co. plans to seek approval early next year for a new insulin it developed after the diabetes treatment fared better than the competition in two late-stage clinical studies. The Indianapolis drugmaker said Thursday peglispro produced statistically significant lower blood sugar levels in patients when compared to people who took the Sanofi insulin Lantus in two late-stage studies of people with type 1 diabetes.
An ambitious health startup from Google is teaming up with biotechnology drugmaker AbbVie in a $500 million joint venture that will try to develop new ways to treat cancer and other diseases such as Alzheimer's. The alliance announced Wednesday calls for Google Inc. and AbbVie Inc. to each invest $250 million in the project. An additional $1 billion may be poured into the project.
Cancerous brain tumors are notorious for growing back despite surgical attempts to remove them, and for leading to a dire prognosis for patients. But scientists are developing a new way to try to root out malignant cells during surgery so fewer or none get left behind to form new tumors. The technology relies on a Raman scanner that can read injected nanoprobes.
Because Brown Univ. biomedical engineering graduate student Molly Boutin needed to study how neural tissues grow from stem cells, she wanted to grow not just a cell culture, but a sphere-shaped one. Cells grow and interact more naturally in 3-D cultures than when they’re confined to thin slides or dishes.